SONOMA PHARMACEUTICALS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SONOMA PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $21.00K, a 19.23% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $23.00K, a 228.57% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $26.00K.
- SONOMA PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $7.00K.
- SONOMA PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $82.00K.
- SONOMA PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $193.00K, a 62.23% decline from fiscal 2021.
- SONOMA PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $511.00K.
- SONOMA PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for fiscal 2018 was $5.00K, a 28.57% decline from fiscal 2017.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-09-30 | $21.00K 10-Q · filed 2026-02-10 | |
| 2025-06-30 | $23.00K 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $82.00K 10-K · filed 2025-06-17 | |
| 2024-09-30 | $26.00K 10-Q · filed 2026-02-10 | |
| 2024-06-30 | $7.00K 10-Q · filed 2026-02-10 | |
| 2022-03-31 | $193.00K 10-K · filed 2023-06-21 | |
| 2021-09-30 | $193.00K 10-Q · filed 2023-02-14 | |
| 2021-03-31 | $511.00K 10-K · filed 2022-07-13 | |
| 2020-12-31 | $22.00K 10-Q · filed 2022-02-11 | |
| 2020-09-30 | $429.00K 10-Q · filed 2022-02-11 | |
| 2018-03-31 | $5.00K 10-K · filed 2019-07-01 | |
| 2017-03-31 | $7.00K 10-K · filed 2018-06-26 | |
| 2013-03-31 | $28.00K 10-K · filed 2014-06-30 | |
| 2012-03-31 | $55.00K 10-K · filed 2013-06-25 | |
| 2011-03-31 | $94.00K 10-K · filed 2012-06-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |